{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:52:44Z","timestamp":1774997564362,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Titin (TTN) variants have been implicated in various types of cardiomyopathy. Allelic variant heterogeneity results in variable clinical phenotypes, which remains a major barrier for effective disease management. We aim to investigate the relationship between\n                      <jats:italic>TTN<\/jats:italic>\n                      variants and their associated cardiomyopathies and clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective observational study was performed to evaluate patients with cardiomyopathy and\n                      <jats:italic>TTN<\/jats:italic>\n                      variants confirmed by whole-exome sequencing (WES) from January 2015 to December 2024. Univariable Cox regression analysis was conducted to identify independent risk factors for major adverse cardiovascular events (MACEs), and receiver operating characteristic analysis was used to determine its capability. In addition, the contribution of combined pathogenic variants with the TTN gene was assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 53 patients were identified with TTN variants, with a\n                      <jats:italic>median onset age of 42.3\u00a0months (IQR 18.5\u201376.1)<\/jats:italic>\n                      , while 48 of 53 (90.50%) individuals had other genetic variants. Among them, 47.17% of patients presented with recurrent heart failure, while late gadolinium enhancement (LGE) was identified in 56.67% of cases that underwent magnetic resonance imaging (MRI) assessment. The variants in the A-band of\n                      <jats:italic>TTN<\/jats:italic>\n                      were most frequently recorded among the patients. Notably, early age-onset disease (HR = 1.008; 95% CI = 1.000\u20131.016;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.037) served as a predictor of MACE in pediatrics with\n                      <jats:italic>TTN<\/jats:italic>\n                      -associated cardiomyopathy, and the optimal cutoff value was calculated as 75.50\u00a0months (specificity 57.1% and sensitivity 75.0%). Unfortunately, the combined genetic disorders failed to establish an association with worse outcomes in the general cohort. However,\n                      <jats:italic>the presence of multiple genetic variants was associated with more severe adverse outcomes<\/jats:italic>\n                      specifically in patients with dilated cardiomyopathy (DCM), with a higher prevalence of MACE occurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In our cohort, early age-onset disease was a predictor of MACE in pediatrics with\n                      <jats:italic>TTN<\/jats:italic>\n                      -associated cardiomyopathy. In addition, the early age of disease onset revealed a higher likelihood of MACE in the first year after diagnosis. Multiple genetic variants with\n                      <jats:italic>TTN<\/jats:italic>\n                      presented more severe adverse outcomes in DCM assessment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1758524","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:10:17Z","timestamp":1774995017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["TTN variants in pediatric cardiomyopathy: a retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Yu","family":"Qiu","sequence":"first","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Hua","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1038\/s41598-019-39911-x","article-title":"Relevance of titin missense and non-frameshifting insertions\/deletions variants in dilated cardiomyopathy","volume":"9","author":"Akinrinade","year":"2019","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/hh2301.100981","article-title":"The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system","volume":"89","author":"Bang","year":"2001","journal-title":"Circ. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"eng","DOI":"10.1161\/circgenetics.117.001959","article-title":"FLNC (Filamin-C): a New(er) player in the field of genetic cardiomyopathies","volume":"10","author":"Brodehl","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11886-021-01550-y","article-title":"The sarcomeric spring protein titin: biophysical properties, molecular mechanisms, and genetic mutations associated with heart failure and cardiomyopathy","volume":"23","author":"Eldemire","year":"2021","journal-title":"Curr. Cardiol. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/01.res.86.11.1114","article-title":"Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity","volume":"86","author":"Freiburg","year":"2000","journal-title":"Circ. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/circulationaha.119.039573","article-title":"Genomics-first evaluation of heart disease associated with titin-truncating variants","volume":"140","author":"Haggerty","year":"2019","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00431-019-03404-w","article-title":"Dilated cardiomyopathy in a national paediatric population","volume":"178","author":"Jammal Addin","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1087359","DOI":"10.3389\/fgene.2022.1087359","article-title":"Enrichment of titin-truncating variants in exon 327 in dilated cardiomyopathy and its relevance to reduced nonsense-mediated mRNA decay efficiency","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/j.1460-2075.1992.tb05222.x","article-title":"Towards a molecular understanding of titin","volume":"11","author":"Labeit","year":"1992","journal-title":"Embo J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/01.res.80.2.290","article-title":"The giant protein titin. Emerging roles in physiology and pathophysiology","volume":"80","author":"Labeit","year":"1997","journal-title":"Circ. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2006.06.035","article-title":"Cardiac titin: structure, functions and role in disease","volume":"375","author":"LeWinter","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"B13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12967-023-04282-5","article-title":"Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing","volume":"21","author":"Lian","year":"2023","journal-title":"J. Transl. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.cardiores.2007.03.029","article-title":"Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction","volume":"77","author":"Linke","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1093\/cvr\/cvab328","article-title":"Titin (TTN): from molecule to modifications, mechanics, and medical significance","volume":"118","author":"Loescher","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/jmg-2023-109513","article-title":"Neuromuscular and cardiovascular phenotypes in paediatric titinopathies: a multisite retrospective study","volume":"61","author":"Meyer","year":"2023","journal-title":"J. Med. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/a:1026053530766","article-title":"Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness","volume":"24","author":"Neagoe","year":"2003","journal-title":"J. Muscle Res. Cell Motil."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1460","DOI":"10.1002\/mgg3.1460","article-title":"Novel heterozygous truncating titin variants affecting the A-band are associated with cardiomyopathy and myopathy\/muscular dystrophy","volume":"8","author":"Rich","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/circulationaha.120.049997","article-title":"Reading frame repair of TTN truncation variants restores Titin quantity and functions","volume":"145","author":"Romano","year":"2022","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/jnd-160158","article-title":"Increasing role of Titin Mutations in neuromuscular disorders","volume":"3","author":"Savarese","year":"2016","journal-title":"J. Neuromuscul. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population","volume":"49","author":"Schafer","year":"2017","journal-title":"Nat. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3389\/fphys.2019.01436","article-title":"The giant protein Titin's role in cardiomyopathy: genetic, transcriptional, and post-translational modifications of TTN and their contribution to cardiac disease","volume":"10","author":"Tharp","year":"2019","journal-title":"Front. Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbrc.2021.12.025","article-title":"Identification of the domains within the N2A region of titin that regulate binding to actin","volume":"589","author":"Tsiros","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e004982","DOI":"10.1161\/circgen.124.004982","article-title":"Analysis of TTN truncating variants in >74 000 cases reveals new clinically relevant gene regions","volume":"18","author":"Vatta","year":"2025","journal-title":"Circ. Genom Precis. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00246-021-02698-8","article-title":"Next-generation sequencing reveals novel genetic variants for dilated cardiomyopathy in pediatric Chinese patients","volume":"43","author":"Wang","year":"2022","journal-title":"Pediatr. Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrcardio.2017.190","article-title":"Role of titin in cardiomyopathy: from DNA variants to patient stratification","volume":"15","author":"Ware","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/circulationaha.119.039521","article-title":"Cronos titin is expressed in human cardiomyocytes and necessary for normal sarcomere function","volume":"140","author":"Zaunbrecher","year":"2019","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7499\/j.issn.1008-8830.2303077","article-title":"Clinical and genetic characteristics of children with primary dilated cardiomyopathy","volume":"25","author":"Zheng","year":"2023","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1758524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:10:20Z","timestamp":1774995020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1758524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":28,"alternative-id":["10.3389\/fgene.2026.1758524"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1758524","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1758524"}}